Anthracyclines are among the most widely used chemotherapy drugs and have been a mainstay of cancer treatment for more than 30 years. Their extraordinary efficacy against numerous solid and hematologic tumors means that they remain first-line drugs today, administered alone or in combination with other therapies. Anthracyclines continue to be the cornerstone of treatment for cancers such as lymphomas, leukemias, sarcomas, gastric cancer, and several subtypes of breast cancer.
This article was originally published on MedicalXpress.com
